Primary Thromboprophylaxis in Ambulatory Cancer Patients ...
VTE risk in the ambulatory setting is 8-19% in cancer, depending on the cancer type, while a matched cohort without cancer was only 1.4%. ... Patient receiving palliative chemotherapy for locally advanced or metastatic disease. Not recommended